ARWR - Arrowhead Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ARWR is currently covered by 8 analysts with an average price target of $84.86. This is a potential upside of $18.47 (27.82%) from yesterday's end of day stock price of $66.39.

Arrowhead Pharmaceuticals's activity chart (see below) currently has 257 price targets and 198 ratings on display. The stock rating distribution of ARWR is 83.33% BUY and 16.67% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 73.76% with an average time for these price targets to be met of 303 days.

Highest price target for ARWR is $80, Lowest price target is $17, average price target is $50.75.

Most recent stock forecast was given by MICHAEL ULZ from MORGAN STANLEY on 26-Nov-2025. First documented stock forecast 05-Mar-2014.

Currently out of the existing stock ratings of ARWR, 15 are a BUY (83.33%), 3 are a HOLD (16.67%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

$48

$-4.7 (-8.92%)

$45

1 months 6 days ago
(26-Nov-2025)

3/4 (75%)

$-9.71 (-16.83%)

32

Buy

$70

$17.3 (32.83%)

$45

1 months 13 days ago
(19-Nov-2025)

25/37 (67.57%)

$29.53 (72.97%)

233

Buy

$60

$7.3 (13.85%)

$60

1 months 13 days ago
(19-Nov-2025)

4/22 (18.18%)

$19.53 (48.26%)

193

Buy

$52

$-0.7 (-1.33%)

$40

1 months 13 days ago
(19-Nov-2025)

9/12 (75%)

$11.53 (28.49%)

345

Buy

$80

$27.3 (51.80%)

$80

7 months 12 days ago
(20-May-2025)

0/22 (0%)

$63.71 (391.10%)

Show more analysts

Please expand the browser size to see the chart

What is ARWR (Arrowhead Pharmaceuticals) average time for price targets to be met?

On average it took 303 days on average for the stock forecasts to be realized with a an average price target met ratio 73.76

Which analyst has the current highest performing score on ARWR (Arrowhead Pharmaceuticals) with a proven track record?

ALETHIA YOUNG

Which analyst has the most public recommendations on ARWR (Arrowhead Pharmaceuticals)?

Alethia Young works at CANTOR FITZGERALD and has 4 price targets and 3 ratings on ARWR

Which analyst is the currently most bullish on ARWR (Arrowhead Pharmaceuticals)?

Esther Rajavelu with highest potential upside - $49.3

Which analyst is the currently most reserved on ARWR (Arrowhead Pharmaceuticals)?

Shawn Egan with lowest potential downside - -$35.7

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?